of this twofold cyclization process, thereby providing
various analogues of the ABC-heterotricyclic framework
associated with, for example, the potent antitumor agent
variolin B (5).6,7
respectively, conditions were readily established (5 mol
% 11, THF, 100 °C, microwave radiation, 1 h) for obtain-
ing the latter product exclusively and in 78% yield. The
structure of pyrimido[1,6-a]indol-1(2H)-one (3) was con-
firmed by single-crystal X-ray analysis.9 Furthermore,
subjection of compound 12 to the reaction conditions
defined above gave product 3 in 75% yield.
Scheme 1
Figure 1. Proposed twofold cyclization process.
The substrate 1 required for initial studies of the pro-
posed twofold cyclization process was readily prepared
according to the reaction sequence shown in Scheme 1.
Thus, the commercially available diyne 6 was treated with
MeLi•LiBr and the lithium diacetylide 7 so-formed was
subjected to Sonogashira cross-coupling with o-iodoani-
line (8) and thereby generating the o-(buta-1,3-diyn-1-yl-)-
substituted aniline 9 (81%).8 Reaction of compound 9
withtrichloroacetylisocyanateaffordedthe corresponding
N-acyl-N0-arylurea 10 (96%), the structure of which was
confirmed by single-crystal X-ray analysis.9 Upon treat-
ment with sodium bicarbonate in aqueous methanol,
compound 10 was converted into the target 1 (76%), the
spectral data for which were in complete accord with the
assigned structure. A variety of conditions were then
examined in an effort to effect the conversion of this
compound into isomer 3.10 Echavarren’s gold(I) catalyst
1111 proved most useful in this regard12 [see the Supporting
Information (SI) for details]. While initial experiments lead
to a chromatographically separable mixture of mono-
and bis-cyclized materials, viz. compounds 12 and 3
This novel conversion was readily extended to a range
ofo-(buta-1,3-diyn-1-yl-)-substitutedN-aryl ureas (13ꢀ28,
Figure 2), thereby giving the corresponding pyrimido-
[1,6-a]indol-1(2H)-ones (29ꢀ41)9 or the related 1H-imidazo-
[1,5-a]indol-3(2H)-ones (42 and 43)13 in uniformly accep-
table yields (Table 1). The substrates used in these studies
were prepared by methods similar to those shown in
Scheme 1. Full details are provided in the SI. There are
several noteworthyoutcomesassociatedwiththetabulated
results. In particular, a range of substituents are tolerated
at the C4 and C5 positions on the substrate (entries 1ꢀ9,
Table 1). Furthermore, the phenyl-capped diynes 22 and
25, which can be prepared by Sonogashira cross-coupling
of compounds 1 and 16 with iodobenzene, also engage
in the anticipated twofold cyclization process (entries 10
and 13) and thereby forming the 3-phenylpyrimido-
[1,6-a]indol-1(2H)-ones 38 and 39, respectively. The corre-
sponding TMS-capped systems 23 and 24, which are read-
ily derived from aniline 9 or its 4-tert-butyl analogue using
minor variations on the reaction sequence shown in
Scheme 1, also undergo the expected cyclization process
(6) (a) Perry, N. B.; Ettouati, L.; Litaudon, M.; Blunt, J. W.; Munro,
M. H. G.; Parkin, S.; Hope, H. Tetrahedron 1994, 50, 3987. (b)
Trimurtulu, G.; Faulkner, D. J.; Perry, N. B.; Ettouati, L.; Litaudon,
M.; Blunt, J. W.; Munro, M. H. G.; Jameson, G. B. Tetrahedron 1994,
50, 3993.
(7) Walker, S. R.; Carter, E. J.; Huff, B. C.; Morris, J. C. Chem. Rev.
2009, 109, 3080.
(8) Liao, H.-Y.; Cheng, C.-H. J. Org. Chem. 1995, 60, 3711.
(9) Details are provided in the Supporting Information (SI).
(10) The parent compound 3 has not been reported previously, but
various derivatives, including biologically active ones, have been de-
scribed; see, for example: (a) Capito, E.; Brown, J. M.; Ricci, A. Chem.
Commun. 2005, 1854. (b) Facoetti, D.; Abbiati, G.; d’Avolio, L.;
Ackermann, L.; Rossi, E. Synlett 2009, 2273. (c) Nakamura, I.; Sato,
Y.; Terada, M. J. Am. Chem. Soc. 2009, 131, 4198. (d) Wang, Z.-J.;
Yang, J.-G.; Yang, F.; Bao, W. Org. Lett. 2010, 12, 3034.
ꢀ
ꢀ
(11) Herrero-Gomez, E.; Nieto-Oberhuber, C.; Lopez, S.; Benet-
Buchholz, J.; Echavarren, A. M. Angew. Chem., Int. Ed. 2006, 45, 5455.
(12) For useful points-of-entry into the literature on gold-catalyzed
cyclization reactions of alkynes, see: (a) Rudolph, M.; Hashmi, A. S. K.
Chem. Soc. Rev. 2012, 41, 2448. (b) Hashmi, A. S. K.; Braun, I.;
Rudolph, M.; Rominger, F. Organometallics 2012, 31, 644. (c) Hashmi,
€
A. S. K.; Lauterbach, T.; Nosel, P.; Vilhelmsen, M. H.; Rudolph, M.;
Rominger, F. Chem.;Eur. J. 2013, 19, 1058. (d) Hansmann, M. M.;
Rudolph, M.; Rominger, F.; Hashmi, A. S. K. Angew. Chem., Int. Ed.
2013, 52, 2593. (e) Reference 1c.
(13) 1H-Imidazo[1,5-a]indol-3(2H)-ones are rare: Katritzky, A. R.;
Singh, S. K.; Bobrov, S. J. Org. Chem. 2004, 69, 9313.
B
Org. Lett., Vol. XX, No. XX, XXXX